Form 4: Penumbra Director Harpreet Grewal Sells Common Stock

Director Harpreet Grewal sold 100 shares of Penumbra Inc stock on April 2, 2026, under a pre-arranged trading plan.

Summary

• Harpreet Grewal, a Director at Penumbra Inc, sold 100 shares of common stock.
• The transaction occurred on April 2, 2026, at a price of $328.22 per share.
• The total value of the sale was approximately $32,822.
• Following the sale, Grewal retains ownership of 8,719 shares.
• The sale was executed under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined schedule for selling stocks to avoid insider trading concerns.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event given the very small transaction size and the use of a pre-established Rule 10b5-1 trading plan.

Positives

• The sale was conducted via a Rule 10b5-1 plan, reducing concerns about opportunistic trading based on non-public information.
• The volume of the sale is very small, representing approximately 1.1% of the director's total reported holdings.

Negatives

• Insider selling, regardless of size, can occasionally be perceived by the market as a minor reduction in alignment with shareholders.

Risks

• Potential for negative investor sentiment if insider selling becomes a broader trend among the company's leadership team.

Future Outlook

No specific forward-looking guidance or financial projections for the company were provided in this ownership disclosure.

Industry Context

StockSavvy.ai notes that minor insider sales in the medical technology sector are common for personal financial planning and, when executed under 10b5-1 plans, typically do not signal fundamental shifts in company outlook.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard best practice among executives at S&P 500 and mid-cap healthcare companies to manage regulatory risk.
• A disposal of roughly 1% of an insider's position is significantly lower than the average liquidation seen during scheduled diversification events in the biotech and med-tech industries.

Corporate Governance

Related Party Transactions

• Director Harpreet Grewal sold 100 shares of common stock to the open market.

Stakeholder Impact

• Minimal impact on shareholders due to the negligible size of the transaction relative to the company's market capitalization.

Next Steps

• Monitor for additional Form 4 filings from other executives to identify any broader selling patterns.

Key Dates

Recommendation

The transaction is too small to warrant a change in investment thesis and was conducted under a pre-planned schedule, suggesting no immediate change in company fundamentals.

Keywords

Penumbra Inc, PEN, Insider Selling, Harpreet Grewal, Form 4, Medical Devices, Rule 10b5-1